Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘Serious and growing threat’

by admin December 10, 2024
December 10, 2024
Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘Serious and growing threat’

Pro-life leaders are sounding off about the ‘serious and growing threat’ of chemical abortion pills after President-elect Trump said he would not restrict access to the pills as president.

Abortion pills, also known as chemical abortion, are now the most common abortion method, accounting for over 60% of all U.S. abortions.

During an interview with NBC’s ‘Meet the Press’ this past weekend, Trump was asked whether he would restrict abortion pill access via executive action.

Trump responded definitively that ‘the answer is no.’

He added: ‘I’ll probably stay with exactly what I’ve been saying for the last two years,’ that abortion is a state, not a federal issue.

Pressed whether he would commit to not restricting abortion pills, the president-elect said: ‘Well I commit’ but noted circumstances may change.

‘Do things change? I think they change,’ he went on, pointing to how President Biden pardoned his son Hunter Biden after repeatedly categorically committing otherwise. 

‘I don’t like putting myself in a position like that,’ he said. ‘So, things do change, but I don’t think it’s going to change at all.’

Chemical abortion access was significantly expanded under the Biden administration, which permanently removed a requirement for the pills to be administered through in-person appointments and allowed the drugs to be delivered via mail or obtained at retail pharmacies like CVS or Walgreens.

In a statement sent to Fox News Digital, Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, said ‘unregulated, mail-order abortion drugs are a serious and growing threat to women’s health and safety, as well as the lives of countless unborn children, all across this country.’

While she criticized the ‘reckless actions’ of the Biden-Harris administration to expand abortion pill access, Dannenfelser said ‘no one who cares about the health and well-being of women can afford to ignore this issue.’ 

Referring to the recent high-profile deaths of Catherine Herring, Amber Thurman, Candi Miller and Alyona Dixon due to abortion pill complications, Dannenfelser said ‘even the pro-abortion media can’t hide that these drugs are killing women and fueling dangerous new forms of domestic violence.’

Kristan Hawkins, president of Students for Life Action, indicated she was optimistic about Trump seeing the danger of unrestricted chemical abortion access, telling Fox News Digital: ‘Many leaders are just now learning about how the pills harm women and the environment.’  

‘We have a lot to talk about with the Trump-Vance administration,’ Hawkins said, adding, ‘President Trump has shown himself to be a reasonable leader who makes decisions based on the best information available.’

‘We hope to be agents of change, providing new information about how the changes made by the Biden-Harris administration on chemical abortion pill policy expose women to injury, infertility, and death, empowers abusers and allows for drinking water pollution through the flushing of medical waste,’ she said. ‘So, we look forward to a frank discussion about what three Democratic Party presidents did to help their friends in Big Abortion Pharma. We can’t wait to give President Trump the new information he needs to act.’ 

Meanwhile, Brian Burch, president of the conservative activism group ‘CatholicVote,’ told Fox News Digital that Trump’s admission that ‘things do change,’ signals ‘he would be open to addressing the overwhelming body of evidence that shows how harmful these drugs are to women.’

‘Big Pharma has exploited far too many women for too long, and the abortion industry should not get a pass when it comes to drug protocols and evidence-based regulations,’ he said. ‘Given President Trump’s pro-life record, together with the personnel he has nominated to key positions, we remain hopeful the new administration will take a serious look at these drugs and act accordingly.’

This post appeared first on FOX NEWS

previous post
Trump nominates Harmeet Dhillon, Mark Paoletta to key posts, backs KC Crosbie for RNC co-chair
next post
Here is who is vying for power in Syria after the fall of Bashar al-Assad

related articles

Hamas releases 4 female hostages as part of...

January 25, 2025

Election 2024: Trump, Harris’ top Hollywood celebrity supporters

November 2, 2024

‘Peace through strength’: Trump and Netanyahu expected to...

February 4, 2025

Trump responds after rebels overtake Syria, ousting longtime...

December 8, 2024

Liz Cheney bashes Trump in new key battleground...

October 29, 2024

Kevin Hassett doubles down on Trump tariffs, says...

April 7, 2025

GOP-led Senate confirming president’s nominees at faster pace...

February 5, 2025

6 top winners and losers who emerged in...

January 1, 2025

CAUGHT ON CAMERA: Turkish leaders brawl at council...

November 9, 2024

‘Light on the truth’: Gabbard announces RFK files...

April 19, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (1,597)
    • Latest News (1,896)
    • Politics (1,964)
    • Stocks (629)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved